Delivery Order SPE2DB22D3501-SPE2DB25FWY86
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $6,647.56 to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on August 4, 2025, with a final delivery date of August 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Ontruzant 150 mg vials, a biosimilar oncology medication, with a ceiling value of $2,305.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award utilized no set-aside designation, reflecting open competition for this medical...
- The Defense Logistics Agency awarded a $35.3K delivery order to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is a child contract action issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency's Medical Supply Chain awarded a $6,766.79 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Ontruzant 150 mg vials. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under open competition. The order is set to be completed by June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $15,445.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ontruzant 420 mg vials, with completion scheduled for September 22, 2025. This competitive award, which included no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Department's Medical Supply Chain awarded a $11,764.70 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Ontruzant 150 mg vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Ontruzant 150 mg vials with a ceiling value of $9,459.31. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for ultimate completion by September 30, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Ontruzant 150 mg vials valued at $10,937.50 on September 23, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by September 24, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ontruzant 420 mg vials, a biosimilar medication used in cancer treatment. This competitively awarded, non-set-aside contract carries a ceiling value of $18,701.64 and is structured as a firm fixed-price delivery order with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ontruzant 150 mg vials, a biosimilar therapeutic product. This firm fixed-price delivery order, valued at $6,850.25, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The ultimate...